The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
M Yuan, LL Huang, JH Chen, J Wu, Q Xu - Signal transduction and …, 2019 - nature.com
Lung cancer is one of the most common cancer in the world. In 2018, there were over 2
million new cases of lung cancer and over 1.7 million deaths were attributed to lung cancer …
million new cases of lung cancer and over 1.7 million deaths were attributed to lung cancer …
MicroRNAs in cancer
G Di Leva, M Garofalo, CM Croce - Annual Review of Pathology …, 2014 - annualreviews.org
MicroRNAs (miRNAs) are small noncoding RNAs that typically inhibit the translation and
stability of messenger RNAs (mRNAs), controlling genes involved in cellular processes such …
stability of messenger RNAs (mRNAs), controlling genes involved in cellular processes such …
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Y Yang, S Li, Y Wang, Y Zhao, Q Li - Signal transduction and targeted …, 2022 - nature.com
Protein tyrosine kinases (PTKs) are a class of proteins with tyrosine kinase activity that
phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal …
phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal …
The quest to overcome resistance to EGFR-targeted therapies in cancer
CR Chong, PA Jänne - Nature medicine, 2013 - nature.com
All patients with metastatic lung, colorectal, pancreatic or head and neck cancers who
initially benefit from epidermal growth factor receptor (EGFR)-targeted therapies eventually …
initially benefit from epidermal growth factor receptor (EGFR)-targeted therapies eventually …
The roles of MicroRNA in lung cancer
KL Wu, YM Tsai, CT Lien, PL Kuo, JY Hung - International journal of …, 2019 - mdpi.com
Lung cancer is the most devastating malignancy in the world. Beyond genetic research,
epigenomic studies—especially investigations of microRNAs—have grown rapidly in …
epigenomic studies—especially investigations of microRNAs—have grown rapidly in …
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
C Cui, J Yang, X Li, D Liu, L Fu, X Wang - Molecular cancer, 2020 - Springer
Circular RNAs (circRNAs), one type of non-coding RNA, were initially misinterpreted as
nonfunctional products of pre-mRNA mis-splicing. Currently, circRNAs have been proven to …
nonfunctional products of pre-mRNA mis-splicing. Currently, circRNAs have been proven to …
Exosomal tumor microRNA modulates premetastatic organ cells
S Rana, K Malinowska, M Zöller - Neoplasia, 2013 - Elsevier
Tumor exosomes educate selected host tissues toward a prometastatic phenotype. We
demonstrated this for exosomes of the metastatic rat adenocarcinoma BSp73ASML (ASML) …
demonstrated this for exosomes of the metastatic rat adenocarcinoma BSp73ASML (ASML) …
Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma
XG Wu, CF Zhou, YM Zhang, RM Yan, WF Wei… - Angiogenesis, 2019 - Springer
Aims Recently, cancer-derived exosomes were shown to have pro-metastasis function in
cancer, but the mechanism remains unclear. Angiogenesis is essential for tumor …
cancer, but the mechanism remains unclear. Angiogenesis is essential for tumor …
Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
Activating mutations in the epidermal growth factor receptor gene occur as early cancer-
driving clonal events in a subset of patients with non-small cell lung cancer (NSCLC) and …
driving clonal events in a subset of patients with non-small cell lung cancer (NSCLC) and …